Effect of Radical Prostatectomy on Involuntary Pelvic Floor Muscle Contraction

September 24, 2019 updated by: Gérard Amarenco, Pierre and Marie Curie University
This study evaluate the effect of radical prostatectomy on involuntary pelvic floor muscle contraction

Study Overview

Status

Completed

Detailed Description

Radical prostatectomy may cause stress urinary incontinence (SUI). That poses problem in terms of quality of life. There are many treatment options available for patients with SUI, but the exact mechanism is not known. We compared, in continent and incontinent men post-radical prostatectomy, the correlation between the temporal course of pelvic floor activation during cough.

Simultaneously, recordings of electromyographic activity of external anal sphincter (EAS EMG) and external intercostal muscle (EIC EMG) during coughing will be made with a pair of pre-gelled electrodes. Cough effort cause an involuntary pelvic contraction. Intercostals muscles recording was chosen because they are one of the muscular components of cough initiation with diaphragm muscle. 24h pad-weighing test is used to quantify urinary incontinence. We will measure the latency between the onset of the EIC EMG and the EAS EMG (RT3), during a cough effort. We will also measure the duration of the contraction, the maximum EAS EMG activity and the area under the curve.

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75020
        • Department of Neuro-urology, Tenon hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 98 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Patients consulting for urodynamic assessment

Description

Inclusion Criteria:

  • Follow in neuro-urology for lower urinary tract symptoms
  • Radical Prostatectomy

Exclusion Criteria:

  • Perineal Radiotherapy
  • Surgery for stress urinary incontinence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Latency (time)
Time Frame: 1 day: During electromyographic recording
The time (latency) between the onset of the external intercostal muscle (EIC EMG) and the electromyographic activity of external anal sphincter (EAS EMG), during a cough effort.
1 day: During electromyographic recording

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration (time)
Time Frame: 1 day: During electromyographic recording
The duration of contraction of external anal sphincter (defined as the time between the onset of the electromyographic activity of external anal sphincter and the end of the electromyographic activity of external anal sphincter).
1 day: During electromyographic recording
Maximum
Time Frame: 1 day: During electromyographic recording
The maximum of contraction of the electromyographic activity external anal sphincter.
1 day: During electromyographic recording
Area under the curve
Time Frame: 1 day: During electromyographic recording
the area under the curve of the electromyographic activity external anal sphincter.
1 day: During electromyographic recording

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 18, 2018

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

July 30, 2018

Study Registration Dates

First Submitted

June 18, 2018

First Submitted That Met QC Criteria

June 28, 2018

First Posted (Actual)

June 29, 2018

Study Record Updates

Last Update Posted (Actual)

September 25, 2019

Last Update Submitted That Met QC Criteria

September 24, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Urinary Tract Symptoms

3
Subscribe